Risultati per: Nuovi possibili trattamenti per il morbo di Alzheimer

Sorgerà all’interno di un parco pubblico

Lo ha evidenziato l’elettrocardiogramma fatto fuori dal campo

La mutazione aumenta l’abilità del cervello di ripulirsi

This finding strengthens the case for early targeting of amyloid-β42 in people at excess risk for AD.

Variations in several biomarkers, including proteins found in cerebrospinal fluid (CSF), might appear 6 to 18 years before a person develops Alzheimer disease, according to a prospective cohort study that included more than 600 participants in China with no family history of the condition.

New England Journal of Medicine, Volume 390, Issue 12, March 2024.

Solo l’1% delle ricerche sono dedicate a condizioni specifiche di genere. Intervista alla neuroscienziata Antonella Santuccione Chadha: «Donne enorme bacino di pazienti sottodiagnosticato»

New England Journal of Medicine, Volume 390, Issue 10, March 2024.

New England Journal of Medicine, Volume 390, Issue 9, Page 866-867, February 2024.

A commercially available blood test that measures levels of a tau protein known as phosphorylated tau 217, or p-tau217, was able to identify people whose brains showed signs of Alzheimer disease pathology, according to data from an observational study. The research involved about 800 participants with and without cognitive impairment.

New England Journal of Medicine, Volume 390, Issue 8, Page 712-722, February 2024.

New England Journal of Medicine, Volume 390, Issue 8, Page 761-763, February 2024.